ID   COLO 699N
AC   CVCL_1993
SY   COLO 699 N; COLO-699N; COLO #699N; Colorado 699N
DR   CLO; CLO_0002554
DR   CLO; CLO_0002555
DR   CLDB; cl843
DR   CLDB; cl844
DR   Cell_Model_Passport; SIDM00912
DR   Cosmic; 687779
DR   ECACC; 93052608
DR   ICLC; HTL95009
DR   Wikidata; Q54814139
CC   Problematic cell line: Contaminated. Shown to be a CHL-1 (or RPMI-7932) derivative (ECACC=93052608). Originally thought to originate from the pleural effusion of a 57 year old female patient with lung adenocarcinoma.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2352; CREM + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-CREM (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Ile228Val (c.682A>G); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=93052608
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1122 ! CHL-1
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//